Skip to main content
. 2018 Dec 10;74(3):633–638. doi: 10.1093/jac/dky483

Figure 1.

Figure 1.

Distribution of ceftazidime/avibactam MICs by BMD and Etest against all 102 Gram-negative isolates evaluated. The horizontal and vertical dashed lines (between 8 and 16 mg/L on the x- and y-axes) represent the MIC susceptibility breakpoint. Shaded boxes indicate MEs (false resistance) as reported by the Etest compared with BMD.